TME Pharma N.V. (ALTME) — Long-term Investment Intensity
TME Pharma N.V. (ALTME) has a Long-term Investment Intensity of 0.3% as of June 2019. Long-term investments of €5.00K represent 0.3% of total assets of €1.98 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check ALTME asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
TME Pharma N.V. Long-term Investment Intensity (2014–2018)
This chart shows how TME Pharma N.V.'s Long-term Investment Intensity has evolved across 3 annual periods from 2014 to 2018. As of June 2019, the intensity stands at 0.3%, reflecting long-term investments of €5.00K against total assets of €1.98 Million EUR. For the complete balance sheet picture, see TME Pharma N.V. (ALTME) total assets.
Annual Long-term Investment Intensity for TME Pharma N.V. (2014–2018)
The table below presents the year-by-year Long-term Investment Intensity for TME Pharma N.V. from 2014 to 2018, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read TME Pharma N.V. total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 0.1% | €5.00K | €4.52 Million | ▼ -0.4 pp |
| 2017 | 0.5% | €5.00K | €929.00K | ▼ -4.6 pp |
| 2014 | 5.1% | €159.00K | €3.09 Million | — |